Fortrea (FTRE) revenue breakdown

Healthcare · Biotechnology · Market cap $1.9B

By segment, Clinical Services is the largest at 91% of fiscal 2023 revenue, growing 1% a year over 2 years.

By region, North America is the largest at 47% of fiscal 2025 revenue; Other grew fastest, 2% a year over 4 years.

Revenue by segment

Fiscal years, as Fortrea reports them in its 10-K filings; fiscal 2023 total $3.1B.

Segments202120222023Share
Clinical Services$2.8B$2.8B$2.8B 91%
Enabling Services$294M$271M$270M 9%

Revenue by region

Fiscal years, as Fortrea reports them in its 10-K filings; fiscal 2025 total $2.7B.

Regions20212022202320242025Share
North America$1.6B$1.4B$1.4B$1.3B$1.3B 47%
Europe$868M$842M$828M$800M$852M 31%
Other$540M$580M$617M$627M$582M 21%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for FTRE.
Open FTRE in Investingly

Questions

Where does Fortrea make its money?

In fiscal 2023, by segment: Clinical Services $2.8B, Enabling Services $270M.

From Fortrea's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.